Benitec Biopharma Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2022 | $3.1M | $6.0M | $4.1M |
| FY2023 | $4.3M | $4.5M | $2.5M |
| FY2024 | $5.0M | $52.2M | $50.9M |
| FY2025 | $2.3M | $99.6M | $97.7M |
| FY2026 | $5.6M | $182.6M | $180.0M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2022 | $3.1M | $6.0M | $4.1M |
| FY2023 | $4.3M | $4.5M | $2.5M |
| FY2024 | $5.0M | $52.2M | $50.9M |
| FY2025 | $2.3M | $99.6M | $97.7M |
| FY2026 | $5.6M | $182.6M | $180.0M |